Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

UK's NHS: 22% of patients wait more than 6 weeks for imaging tests

Recent statistics from the National Health Service (NHS) show that almost a quarter of patients wait more than six weeks for key diagnostic tests such as MRI and CT scans, the BBC reported on Aug. 27.

Perivascular fat attenuation index CT scans showing the amount coronary wall inflammation. This measure is being tested in trials to see if it can accurately predict which coronary artery lesions will progress to cause heart attacks.

Novel cardiac imaging biomarker could predict risk of coronary inflammation, heart attack

A team of international researchers has developed a new imaging biomarker able to non-invasively predict a patient’s risk of coronary inflammation and heart attack, according to research published Aug. 28 in The Lancet.

xPerivascular fat attenuation index CT scans from a drug study showing a reduction in coronary wall inflammation. This measure is being tested in trials to see if it can accurately predict which coronary artery lesions will progress to cause heart attacks. The method also can show a reduction in risk with therapy, as seen here.

FAI helps quantify vascular inflammation, predict future CVD events in cardiac imaging patients

The addition of perivascular fat attenuation to routine coronary computed tomography angiography (CTA) improves risk stratification in heart patients, according to research presented at the European Society of Cardiology (ESC)’s annual symposium in Munich, surpassing current prognostic models to re-classify and predict cardiac deaths with more accuracy.

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

Thumbnail

CT angiography may improve treatment decisions for stable chest pain

Patients with stable chest pain who were evaluated with coronary CT angiography (CTA) were significantly less likely to experience a heart attack or die from coronary heart disease (CHD) within five years compared to individuals who received standard testing, researchers reported in the New England Journal of Medicine.

Thumbnail

Coronary CT angiography could reduce 5-year risk of heart attack by 41%

Researchers found coronary computed tomography angiogram (CTA) in addition to standard cardiac testing may reduce patients at risk for coronary heart disease or a heart attack.

Thumbnail

Experts debate clinical impact of HeartFlow's noninvasive cardiac imaging

“The technology’s usefulness may come down to a deeper question: How effective are stents for treating heart disease, and do you even need to know whether an artery is open or not?” according to an article published Aug. 27 by Forbes.

Thumbnail

Risk of stroke, brain atrophy linked to modifiable lifestyle choices with MRI

Researchers have found young adults' lifestyle choices can increase their risk of stroke and dementia later in life, even with good cardiovascular health and without evidence of cerebrovascular disease, according to an Aug. 21 study in the Journal of the American Medical Association.